CN Patent

CN101820838B — 采用口腔经粘膜剂型的用于程序镇静和镇痛的组合物和方法

Assigned to Talphera Inc · Expires 2013-06-05 · 13y expired

What this patent protects

提供了用于程序镇静和镇痛的剂型及其使用方法，所述剂型包含诸如舒芬太尼的类鸦片与诸如三唑仑的苯并二氮杂卓类的组合，其通过口腔经粘膜的途径给药。

USPTO Abstract

提供了用于程序镇静和镇痛的剂型及其使用方法，所述剂型包含诸如舒芬太尼的类鸦片与诸如三唑仑的苯并二氮杂卓类的组合，其通过口腔经粘膜的途径给药。

Drugs covered by this patent

sufentanil-citrate (SUFENTANIL CITRATE)

Patent Metadata

Patent number: CN101820838B
Jurisdiction: CN
Classification: —
Expires: 2013-06-05
Drug substance claim: No
Drug product claim: No
Assignee: Talphera Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.